Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Free Cash Flow Generation Index
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Free Cash Flow Generation Index of 0.91x as of September 2024. Free cash flow of TL30.46 Million represents 1% of operating cash flow (TL33.37 Million). See working capital position of Oncosem Onkolojik Sistemler Sanayi ve Ti to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Free Cash Flow Generation Index (2020–2022)
Historical FCF Generation Index trend for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 3 annual periods. Explore Oncosem Onkolojik Sistemler Sanayi ve Ti cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2022)
Year-by-year Free Cash Flow Generation Index for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For the full company profile including market capitalisation, see Oncosem Onkolojik Sistemler Sanayi ve Ti market cap and net worth.
| Year | FCG Index | Free Cash Flow (TRY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.51x | TL26.67 Million | TL52.69 Million | TL26.02 Million | ▼ -49.4% |
| 2021 | 1.00x | TL51.68 Million | TL51.68 Million | TL0.00 | ▲ +0.0% |
| 2020 | 1.00x | TL19.41 Million | TL19.41 Million | TL0.00 | — |